Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 5 of 5 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Kriya Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Kriya Therapeutics develops AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, thyroid eye disease (TED) and other indications. This location is the company's internal manufacturing facility. | Location Morrisville |
| |
Company Metabolon Inc. | Activity: Contract Research and Testing | Company Description Metabolon is advancing the science of metabolomics for the clinic and life sciences research. Its technology and data are used for biomarker discovery, diagnostic test development, and genomics and population health initiatives. | Location Morrisville |
| |
Company Novo Nordisk Pharmaceutical Industries LP (API facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Active Pharmaceutical Ingredient (API) facility produces the API for an oral diabetes treatment through fermentation, purification and recovery processes. | Location Clayton |
| |
Company Novo Nordisk Pharmaceutical Industries LP (IFP facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Clayton facility manufactures insulin, GLP-1 products and prefilled delivery devices for the treatment of diabetes. | Location Clayton |
| |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham |